In the United States, the Pharmaceutical market can be categories into two types of drugs Traditional as well as Specialty drugs. In recent times, Specialty drugs have gained a substantial foothold in the US market, and as estimated, it tends to gain more momentum in the upcoming years. For this, the credit goes to the companies initiatives towards Research and Developments (R&D’s) of these drugs. As per the analysis, it is expected that United States Specialty Pharmaceutical Market will be US$ 387 Billion by 2026.
During the years, Specialty pharmaceutical has changed much due to speciality drugs being in the final stages of development in the United States. Speciality drugs are for rare and chronic diseases, and the drugs fall under this category are much expensive compared to traditional medications. Research has shown that a large portion of the US population was ageing and more people are prone towards chronic and rare diseases like cancer, Autoimmune, Multiple sclerosis.
In the year 2018, the FDA has approved 21 new molecular entities. Out of these products, 12 are regarded as speciality pharmaceutical based on variables such as indication and designed use population, administrative and tracking considerations, price and restricted delivery procedures. Dating back five years, spending on speciality drugs has almost doubled in the United States.
An ageing population, rise in the net per capita medicine spending on speciality drugs, improving life expectancy rate, the prevalence of chronic diseases are likely to boost the United States Specialty pharmaceuticals market at a staggering rate in upcoming years.
The report titled “United States Specialty Pharmaceuticals Market, by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, Age-related macular degeneration (AMD), Human Growth Hormones (HGH) Others), Company (CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Analysis” provides a complete analysis of United States Specialty Pharmaceutical Market.
All the 9 Diseases have been studied from two points
- Market
- Drugs Pipeline
Application - The Report Covers the Market, Drugs Pipelines of 9 diseases
1. Oncology
2. Autoimmune
3. Immunology
4. HIV
5. Multiple Sclerosis
6. Hematology
7. Age-related macular degeneration (AMD)
8. Human Growth Hormones (HGH)
9. Others
All the key players have been covered from 3 Viewpoints
- Overview
- Recent Developments
- Revenue Analysis
Company Analysis
- CVS Health
- Endo International
- UnitedHealth Group Incorporated
- Recordati Pharmaceuticals
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
4.3 Trend and Opportunities
5. Market Analysis - United States Specialty Pharmaceuticals
5.1 Market
5.2 Specialty Drug Pipeline
6. Share Analysis
6.1 Applications
6.2 Segments
6.2.1 Traditional
6.2.2 Specialty
7. By Applications
7.1 Oncology
7.1.1 Market
7.1.2 Pipelines
7.2 Autoimmune
7.2.1 Market
7.2.2 Pipelines
7.3 HIV
7.3.1 Market
7.3.2 Pipelines
7.4 Immunology
7.4.1 Market
7.4.2 Pipelines
7.5 Multiple Sclerosis (MS)
7.5.1 Market
7.5.2 Pipelines
7.6 Hematology
7.6.1 Market
7.7 Age-related macular degeneration (AMD)
7.7.1 Market
7.7.2 Pipelines
7.8 Human Growth Hormones (HGH)
7.8.1 Market
7.8.2 Pipelines
7.9 Others
8. Key Players Analysis
8.1 CVS Health
8.1.1 Overview
8.1.2 Recent Developments
8.1.3 Revenues
8.2 Endo International
8.2.1 Overview
8.2.2 Recent Developments
8.2.3 Revenues
8.3 UnitedHealth Group Incorporated
8.3.1 Overview
8.3.2 Recent Developments
8.3.3 Revenues
8.4 Recordati Pharmaceuticals
8.4.1 Overview
8.4.2 Recent Developments
8.4.3 Revenues
List of Tables:
Table-01: Specialty New Product Approvals in the Past Twelve Months
Table-02: United States - Market Share By Applications, (Percent), 2015 - 2020
Table-03: United States - Forecast for Market Share By Applications, (Percent), 2021 - 2026
Table-04: United States - Oncology Specialty Drug/R&D Pipeline
Table-05: Drugs Pipelines - 2020
Table-06: Specialty Drugs Pipeline - 2020
List of Figures:
Figure-01: Excess Revenues Earned Through Premium Pricing Of Products In The US As A Percentage Of The Company’s Global Research And Development Expenditures, 2015
Figure-02: United States - Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
Figure-03: United States - Forecast For Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
Figure-04: United States - Market Share By Traditional vs Specialty, (Percent), 2015 - 2020
Figure-05: United States - Forecast for Market Share By Traditional vs Specialty, (Percent), 2021 - 2026
Figure-06: By Application - Oncology Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
Figure-07: By Application - Forecast for Oncology Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
Figure-08: By Application - Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
Figure-09: By Application - Forecast for Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
Figure-10: By Application - HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
Figure-11: By Application - Forecast for HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
Figure-12: By Application - Immunology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
Figure-13: By Application - Forecast for Immunology Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-14: By Application - Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
Figure-15: By Application - Forecast for Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-16: By Application - Hematology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
Figure-17: By Application - Forecast for Hematology Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-18: By Application - Age-Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
Figure-19: By Application - Forecast for Age-Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-20: By Application - Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
Figure-21: By Application - Forecast for Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-22: By Application - Others Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-23: By Application - Forecast for Others Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
Figure-24: Forecast For CVS Health Revenue Market (Million US$), 2021 - 2026
Figure-25: Global - Endo International Specialty Products Revenue (Million US$), 2015 - 2020
Figure-26: Global - Forecast For Endo International Specialty ProductsRevenue (Million US$), 2021 - 2026
Figure-27: Global - UnitedHealth Group Incorporated Revenue (Million US$), 2015 - 2020
Figure-28: Global - Forecast For United Health Group Incorporated Revenue (Million US$), 2021 - 2026
Figure-29: Global - Recordati Pharmaceuticals Ltd Revenue (Million US$), 2015 - 2020
Figure-30: Global - Forecast For Recordati Pharmaceuticals Ltd Revenue (Million US$), 2021 - 2026
Companies Mentioned
- CVS Health
- Endo International
- Recordati Pharmaceuticals
- UnitedHealth Group Incorporated
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
